Complete response of esophageal small cell carcinoma amrubicin treatment

Journal of Infection and Chemotherapy

Volumn 19, Issue 4, 2013, Pages 770-775

  Nagasaki, Eijiro ^a   Yuda, Masami ^a   Tanishima, Yuichiro ^a   Arakawa, Yasuhiro ^a   Kobayashi, Kazuma ^a   Sakuyama, Toshikazu ^a   Inoue, Daisuke ^a   Nishikawa, Katsunori ^a   Kobayashi, Masao ^a   Omura, Nobuo ^a   Kobayashi, Tadashi ^a   Aiba, Keisuke ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amrubicin; Chemotherapy; Small cell carcinoma of the esophagus

Indexed keywords

AMRUBICIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; IRINOTECAN; NERVE CELL ADHESION MOLECULE; NEURON SPECIFIC ENOLASE; PROGASTRIN RELEASING PEPTIDE; SYNAPTOPHYSIN;

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIPLOPIA; DRUG RESPONSE; DYSPHAGIA; ESOPHAGEAL SMALL CELL CARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS METASTASIS; GAMMA KNIFE RADIOSURGERY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGRESSION FREE SURVIVAL; SMALL CELL CARCINOMA; TUMOR REGRESSION;

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED;

EID: 84882257299     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0510-8     Document Type: Article

References (23)

1. The Japanese Society for Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan (1995, 1996, 1997), 2nd ed. 2001.
2. The Japanese Society for Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan (1998, 1999), III ed. Tokyo: Japanese Society for Esophageal Diseases; 2002.
3. Beyer KL, Marshall JB, Diaz-Arias AA, Loy TS. Primary small-cell carcinoma of the esophagus. Report of 11 cases and review of the literature. J Clin Gastroenterol. 1991;13:135-41.
4. Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22:2730-9.
5. Chin K, Baba S, Hosaka H, Ishiyama A, Mizunuma N, Shinozaki E, et al. Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience. Jpn J Clin Oncol. 2008;38:426-31.
6. Yana T, Negoro S, Takada M, Yokota S, Takada Y, Sugiura T, et al. Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study. Invest New Drugs. 2007;25:253-8.
7. Inoue A, Sugawara S, Yamazaki K, Maemondo M, Suzuki T, Gomi K, et al. Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402. J Clin Oncol. 2008;26:5401-6.
8. Jotte R, Conkling P, Reynolds C, Galsky MD, Klein L, Fitzgibbons JF, et al. Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy. J Clin Oncol. 2011;29:287-93.
9. Ettinger DS, Jotte R, Lorigan P, Gupta V, Garbo L, Alemany C, et al. Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer. J Clin Oncol. 2010;28:2598-603.
10. Walenkamp AM, Sonke GS, Sleijfer DT. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma. Cancer Treat Rev. 2009;35:228-36.
11. Medgyesy CD, Wolff RA, Putnam JB Jr, Ajani JA. Small cell carcinoma of the esophagus: the University of Texas M.D. Anderson Cancer Center experience and literature review. Cancer (Phila). 2000;88:262-7.
12. Huncharek M, Muscat J. Small cell carcinoma of the esophagus. The Massachusetts General Hospital experience, 1978 to 1993. Chest 1995;107:179-181.
13. Ku GY, Minsky BD, Rusch VW, Bains M, Kelsen DP, Ilson DH. Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol. 2008;19:533-7.
14. Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med. 2002;346:85-91.
15. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-247
16. Hanada M, Mizuno S, Fukushima A, Saito Y, Noguchi T, Yamaoka T. A new antitumor agent amrubicin induces cell growth inhibition by stabilizing topoisomerase II-DNA complex. Jpn J Cancer Res. 1998;89:1229-38.
17. Onoda S, Masuda N, Seto T, Eguchi K, Takiguchi Y, Isobe H, et al. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol. 2006;24:5448-53.
18. Kobayashi M, Matsui K, Iwamoto Y, Ebi N, Oizumi S, Takeda K, et al. Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301. J Thorac Oncol. 2010;5:1075-80.
19. Isobe T, Yanai S, Kusaba H, Yada S, Kuroda Y, Tamiya S, et al. Effective monotherapy with amrubicin for a refractory extrapulmonary small-cell carcinoma of the liver. Case Rep Med. 2009;2009:538081.
20. Katou M, Soga N, Onishi T, Arima K, Sugimura Y. Small cell carcinoma of the prostate treated with amrubicin. Int J Clin Oncol. 2008;13:169-72.
21. Asayama M, Fuse N, Yoshino T, Yano T, Tahara M, Doi T, et al. Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases. Cancer Chemother Pharmacol. 2011;68:1325-1330.
22. Auperin A, Arriagada R, Pignon JP, Le Pechoux C, Gregor A, Stephens RJ, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 1999;341:476-84.
23. Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007;357:664-72.